Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2006-04-14
2008-09-30
Stucker, Jeffrey (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S142100, C424S143100, C530S300000, C530S350000, C530S387100
Reexamination Certificate
active
07429379
ABSTRACT:
A method of modulating signal transduction and/or cleavage in Tumor Necrosis Factor Receptors (TNF-Rs) is provided. Peptides or other molecules may interact either with the receptor itself, or with effector proteins interacting with the receptor, thus modulating the normal functioning of the TNF-Rs. Such peptides or other molecules may be employed for prophylactic and therapeutic applications in TNF associated diseases.
REFERENCES:
patent: 0 393 438 (1990-10-01), None
patent: 0 444 560 (1991-09-01), None
Sol et al. (1999). J virol. 73, 8762-8770.
Kuebler et al (2000). J. Clin. Invest. 105, 905-913.
Kameyama et al (2006). Bioconjugat Chem. 17, 597-602.
Schwarze et al (1999) Science. 285, 1569-1572.
Carson (1993). PNAS. 90, 7427-7428.
Aggarwal BB, “Structure of tumor necrosis factor and its receptor”,Biotherapy3(2):113-120 (1991).
Engelmann et al. “Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity”,J Biol Chem265(24):14497-14504 (1990).
Espevik et al, “Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor”,J Exp Med171(2):415-426 (1990).
Fitzgerald et al (Eds),The Cytokine Facts Book, Human TNF-R p55 and p75, p. 478 (2001).
Hwang et al, “A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro”,Proc R Soc Lond B Biol Sci245(1313):115-9 (1991).
Lie et al, “Identification of the binding site of 55kDa tumor necrosis factor receptor by synthetic peptides”,Biochem Biophys Res Commun188(2):503-9 (1992).
Porteau et al, “Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils”,J Biol Chem266(28):18846-18853 (1991).
Shalaby et al, “Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors”,J Exp Med172(5):1517-20 (1990).
Brakebusch Cord
Wallach David
Browdy and Neimark
Standley Steven H
Stucker Jeffrey
Yeda Research and Development Co. Ltd.
LandOfFree
TNF receptor action modulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with TNF receptor action modulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TNF receptor action modulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3986210